Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

May 13, 2024

https://www.globenewswire.com/news-release/2024/05/13/2880932/0/en/Turnstone-Biologics-Corp-Reports-First-Quarter-2024-Financial-Results-and-Provides-Recent-Business-Highlights.html

SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) — Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq:TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today reported financial results for the first quarter ended March 31, 2024, and provided recent business highlights.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.